Clinical trial · Observational
MRI Detection of Microbleeds in Glioma Patients
Detection of Microbleeds With MRI (SWI Sequences) in Glioma Patients
NCT02899663CI-TRIAL-00023861SWIGLIcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Systematic retrospective medical chart and medical imaging file review of all patients receiving brain MRI for the follow-up of glioblastoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glioblastoma | Glioblastoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number of microbleeds diagnosed with MRI (susceptibility weighted imaging sequence)
- timeFrame
- At the time of each MRI conducted within 5 years after diagnosis
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients * Diagnosed with brain glioblastoma * Receiving treatment with cranial radiotherapy and/or chemotherapy * Having at least one follow-up MRI conducted that used a susceptibility weighted imaging sequence Exclusion Criteria: * Underage * Absence of formal diagnosis of glioblastoma * No available medical imaging file with MRI susceptibility weighted imaging sequence
References
Publications (0)
Data not yet available
No reference posted for this study.